Global Health: A Look Ahead at Trends in Seven Key Areas
Client Alert | 1 min read | 04.07.22
Crowell & Moring International (CMI) commemorates “World Health Day” with the publication of our compiled health policy forecast for the year. “Global Health: A Look Ahead at Trends in Seven Key Areas” explores global health trends and challenges at the forefront of business, government and public concerns.
This forecast provides a concise outlook on key issues affecting health in 2022 and beyond. Each is an area where CMI works with our partners to make a meaningful difference. Each is an area that merits attention and concerted action to improve health. We offer our perspectives on:
- Vaccines
- Health Financing
- Antimicrobial Resistance (AMR)
- Oncology/Cervical Cancer
- Women’s Health
- Rare Diseases
- AI/Digital Health
Based in Washington, DC and Singapore, C&M International has a commitment to advancing health through our work with clients to help shape policy, regulatory, and commercial landscapes around the global. For more information on C&M International and its capabilities, please visit cmintl.com.
Contacts
Insights
Client Alert | 4 min read | 12.04.25
District Court Grants Preliminary Injunction Against Seller of Gray Market Snack Food Products
On November 12, 2025, Judge King in the U.S. District Court for the Western District of Washington granted in part Haldiram India Ltd.’s (“Plaintiff” or “Haldiram”) motion for a preliminary injunction against Punjab Trading, Inc. (“Defendant” or “Punjab Trading”), a seller alleged to be importing and distributing gray market snack food products not authorized for sale in the United States. The court found that Haldiram was likely to succeed on the merits of its trademark infringement claim because the products at issue, which were intended for sale in India, were materially different from the versions intended for sale in the U.S., and for this reason were not genuine products when sold in the U.S. Although the court narrowed certain overbroad provisions in the requested order, it ultimately enjoined Punjab Trading from importing, selling, or assisting others in selling the non-genuine Haldiram products in the U.S. market.
Client Alert | 21 min read | 12.04.25
Highlights: CMS’s Proposed Rule for Medicare Part C & D (CY 2027 NPRM)
Client Alert | 11 min read | 12.01.25
